Anti-OX40 Antibody in Head and Neck Cancer Patients
Clinical trial NCT02274155 · COMPLETED
Trial details
- NCT number
- NCT02274155
- Sponsor
- Providence Health & Services
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-12
- Primary completion
- 2017-09-17
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.